Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics.
about
The malabsorption of commonly occurring mono and disaccharides: levels of investigation and differential diagnosesRANTES, eotaxin and eotaxin-2 expression and production in patients with aspirin triadCurrent concepts in therapy of chronic rhinosinusitis and nasal polyposisRelease of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patientsIncreased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthmaAsthma, nasal polyposis and ulcerative colitis: a new perspectiveNuclear factor-kappaB activity is down-regulated in nasal polyps from aspirin-sensitive asthmaticsA new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in vitro diagnosis of hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugsThe flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndromeSignal transduction pathways (MAPKs, NF-κB, and C/EBP) regulating COX-2 expression in nasal fibroblasts from asthma patients with aspirin intolerance.Aspirin sensitivity and chronic rhinosinusitis with polyps: a fatal combination.Chronic calcium pyrophosphate crystal inflammatory arthritis induced by extreme hypomagnesemia in short bowel syndromeSalicylate intolerance: pathophysiology, clinical spectrum, diagnosis and treatment.Irritable bowel syndrome and food interaction.Prostaglandin D2-supplemented "functional eicosanoid testing and typing" assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study.Effect of in vitro aspirin stimulation on basophils in patients with aspirin-exacerbated respiratory disease.Immunomodulatory treatments for aspirin exacerbated respiratory disease.Nonallergic drug hypersensitivity reactions.Pathogenesis of aspirin-exacerbated respiratory disease and reactions.Exhaled Eicosanoids following Bronchial Aspirin Challenge in Asthma Patients with and without Aspirin Hypersensitivity: The Pilot Study.A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma.Development of a genetic marker set to diagnose aspirin-exacerbated respiratory disease in a genome-wide association study.Pathogenic Mechanisms and In Vitro Diagnosis of AERD.Low-dose aspirin desensitization in individuals with aspirin-exacerbated respiratory disease.Effect of apical root-end filling materials on gingival fibroblasts.Expression of arachidonate metabolism enzymes and receptors in nasal polyps of aspirin-hypersensitive asthmatics.Characteristics of recurrent chronic rhinosinusitis after previous surgical therapy.Non-steroidal anti-inflammatory drugs-induced urticaria and angioedema: more research on mechanisms needed.Strategy for NSAID administration to aspirin-intolerant asthmatics in combination with PGE2 analogue: a theoretical approach.Role of expression of prostaglandin synthases 1 and 2 and leukotriene C4 synthase in aspirin-intolerant asthma: a theoretical study.Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.Porphyromonas gingivalis induces RANKL in T-cells.Aspirin-intolerant asthma: role of cyclo-oxygenase enzymes
P2860
Q26822538-C2B8FFD2-1A99-4FCC-A38B-AA0758DF2E95Q28166107-FE2254B8-B70A-491E-A8C1-B5E8517DFA8EQ28176799-96BE9CDB-A058-4CEF-BD18-45A1C4F5A500Q28190812-641C2161-7803-4EF0-9EF0-89BA692E2027Q28193535-D6DF0D1F-511D-4796-9707-FFC06C6CB624Q28193641-B76C138B-6F2B-4D78-AD82-E3A09544148BQ28195310-14FF7EFE-0C13-4278-8882-7FAE2D9426CFQ28211974-46326FEC-8A8F-4348-A294-F4482AAEE730Q28212311-10D25D7B-6FB5-459A-B89B-0179AC3782A6Q30459926-CC7A3A4D-B9A9-40D2-B22B-8A9B26C69BABQ30464467-AF960C2F-3FA2-4C5C-89AD-3A897F1D6F9FQ31097864-3675E69E-BA6D-4D9C-AD6C-6027C18AD739Q33487197-591FC19F-9C04-41DD-80F0-BD590444FFA3Q33958891-4B3DAA73-560F-4CFF-AB98-1316508DF196Q34812525-FAFEEF4C-52E4-4C36-9E2B-93EAD6EA850DQ37459192-A854B11B-571A-49BC-88C6-BB7C486FF5EFQ37530831-6B5C14DB-19BF-4520-9486-2333C8916E4CQ38029476-1E0694B3-5468-45CE-B6DE-8800BB9D2D75Q38103710-4E67B8FE-F7C6-4E48-B230-D4BF0D88038AQ40629569-B017B51E-A9C3-4360-A112-52A18D28BFC3Q40836591-FF4D582F-7B0D-4F86-8E9A-C30A769B93A5Q41365516-DB79B2AE-414F-466D-A7F7-1E1004E086DBQ41898865-6C9BC1D6-4674-401D-8EE1-4FA52ABEAD03Q43881393-965CAEE4-0391-4187-9ED2-5A47061AB029Q44570099-C728A2C0-540E-4003-9379-0657B6DF4FE6Q46034358-521CA032-404E-4795-9CAD-72A8DA4BA680Q46528249-6E73257E-B6C5-4FB2-A05E-F13D74453653Q46559672-EB4ABB64-2770-48E1-8E30-2620EBBB0D8FQ51488662-8BF36CB5-606E-4417-AFA2-8B05251C23E0Q51601933-9705EA77-2432-4B9A-A22F-EBB61BD580C6Q51703960-625622BE-C792-42C3-844B-FB5C50E77E9BQ54429503-5C70A288-C452-43B0-9CED-1CBE196344FDQ56504672-B5357C34-E2AD-4FD9-8F44-3CA070C6FCE1
P2860
Dynamics of eicosanoids in peripheral blood cells during bronchial provocation in aspirin-intolerant asthmatics.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Dynamics of eicosanoids in per ...... aspirin-intolerant asthmatics.
@en
Dynamics of eicosanoids in per ...... aspirin-intolerant asthmatics.
@nl
type
label
Dynamics of eicosanoids in per ...... aspirin-intolerant asthmatics.
@en
Dynamics of eicosanoids in per ...... aspirin-intolerant asthmatics.
@nl
prefLabel
Dynamics of eicosanoids in per ...... aspirin-intolerant asthmatics.
@en
Dynamics of eicosanoids in per ...... aspirin-intolerant asthmatics.
@nl
P2093
P1476
Dynamics of eicosanoids in per ...... aspirin-intolerant asthmatics.
@en
P2093
P304
P356
10.1183/09031936.99.13363899
P577
1999-03-01T00:00:00Z